Food allergy

FOOD_ALLERGY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L23.6 Cause of death: ICD-10 — L23.6 2 out of 7 registries used, show all original rules.	117
4. Check minimum number of events None	117
5. Include endpoints None	117
6. Filter based on genotype QC (FinnGen only)	109

Control definitions (FinnGen only)

Control exclude: ASTHMA_ALLERG

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L23
Name in latin: Eczema allergicum ex contactu nutrimentorum

NAME	FOOD_ALLERGY
CONTROL_EXCLUDE	ASTHMA_ALLERG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L236
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L236
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Food allergy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1444	806	635
Only index persons	1161	681	480
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.02
Only index persons	0.02	0.03	0.02
Median age at first event (years)
Whole population	15.11	23.09	4.90
Only index persons	19.59	26.47	9.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	109	83	26
Unadjusted period prevalence (%)	0.03	0.03	0.01
Median age at first event (years)	35.60	37.38	29.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
112: Matched controls
1120

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

+∞

161.6

112

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

12.5

38.2

XQ800

NOMESCO Finland

Prick test

11.0

28.6

C01CA24

ATC

epinephrine; parenteral

9.0

23.3

L20.0

ICD-10 Finland

Besnier prurigo

7.1

20.6

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

5.9

11.3

E0000UV, ,

ATC

3.9

10.9

365

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

8.8

10.3

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

44.3

10.2

E000002, ,

ATC

4.3

9.8

XQ802

NOMESCO Finland

Epicutan test

9.3

D07AC13

ATC

mometasone; topical

3.4

8.9

190

R06AE09

ATC

levocetirizine; oral

4.0

8.7

E000001, ,

ATC

3.3

7.9

161

H02AB06

ATC

prednisolone; systemic

3.1

7.8

332

T78.4

ICD-10 Finland

Allergy, unspecified

6.3

7.3

J45.9

ICD-10 Finland

Asthma, unspecified

3.4

7.2

112

J30.3

ICD-10 Finland

Other allergic rhinitis

7.3

6.9

R06AX27

ATC

desloratadine; oral

2.8

6.7

262

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

15.5

6.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.3

6.4

D07AD01

ATC

clobetasol; topical

3.4

6.3

R06AE07

ATC

cetirizine; oral

2.7

6.2

380

D07AB08

ATC

desonide; topical

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018001) Oat IgE Ab [Units/volume] in Serum

+∞

5.24

1.2

0.0

0.55

—

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

5.01

4.75

1.4

1.3

1.30

2.06

u/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

5.29

3.11

3.9

2.4

1.43

1.09

mmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

5.66

2.91

6.6

2.8

—

(44813793) Dust mix specific IgE antibody measurement

8.64

2.77

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3.56

2.68

4.5

2.3

24.56

24.05

mmol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

4.90

2.64

4.3

2.3

6.20

6.58

mmol/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.10

2.49

3.5

2.7

0.72

0.58

1.04

(3005322) IgE [Units/volume] in Serum or Plasma

2.36

2.39

2.4

1.4

381.19

394.17

u/ml

0.01

(3035285) Chloride [Moles/volume] in Venous blood

5.75

2.23

3.4

2.4

107.80

105.78

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

5.75

2.23

3.4

2.4

1.18

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

5.75

2.23

3.4

2.4

3.76

3.88

mmol/l

—

(3026782) Osmolality of Urine

165

1.93

2.18

4.4

2.3

494.43

529.48

mosm/kgh2o

0.26

141

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

852

2.20

2.06

3.4

3.7

1.17

1.25

mmol/l

0.67

805

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

3.23

2.05

1.1

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.71

2.00

6.1

2.7

47.65

51.76

—

(3041096) Erythrocytes [Presence] in Urine by Automated

301

1.70

1.88

4.3

3.2

0.00

0.01

estimate

0.49

(3000494) Fungus identified in Specimen by Culture

111

1.98

1.83

1.8

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

524

1.63

1.73

4.0

3.5

0.00

estimate

-0.00

112

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2.70

1.69

1.1

1.5

—

12.96

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

392

1.61

1.67

4.0

3.4

0.00

0.01

estimate

0.50

(3009261) Glucose [Presence] in Urine by Test strip

528

1.61

1.65

4.0

3.6

0.00

estimate

-0.00

108

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.17

1.61

1.5

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

520

1.60

1.61

4.1

3.5

0.00

estimate

-0.00

112

(40768443) Skin Pathology biopsy report

2.53

1.57

1.1

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

112

1077

+∞

1.56

21.5

20.4

135.42

135.62

g/l

0.06

112

1069

(3024731) MCV [Entitic mean volume] in Red Blood Cells

112

1076

+∞

1.55

21.0

20.2

89.92

89.96

0.03

112

1068

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

112

1076

+∞

1.55

21.2

20.7

39.71

40.55

0.61

112

1068

(3035941) MCH [Entitic mass]

112

1076

+∞

1.55

21.1

20.2

30.04

30.05

0.01

112

1068

(3007853) Bacteria identified in Skin by Aerobe culture

110

1.88

1.55

1.8

1.7

—

(3001604) Monocytes [#/volume] in Blood

517

1.56

1.47

6.8

6.5

0.55

0.54

e9/l

0.13

462

(3006315) Basophils [#/volume] in Blood

519

1.54

1.43

6.8

6.5

0.04

e9/l

0.44

462

(3021589) Normoblasts [#/volume] in Blood

465

1.51

1.34

11.7

9.4

0.00

e9/l

0.53

379

(3047007) Chlamydophila sp Ab [Presence] in Serum

2.58

1.32

1.2

—

(3035715) Granulocytes [#/volume] in Blood

2.86

1.30

2.4

4.8

3.93

4.70

e9/l

—

(3019198) Lymphocytes [#/volume] in Blood

538

1.50

1.26

7.0

6.6

1.92

2.14

e9/l

0.83

492

(3002582) Erythrocytes [#/volume] in Urine

291

1.52

1.24

3.9

3.2

19.50

267.57

e6/l

0.57

219

(3019150) Specific gravity of Urine by Refractometry

220

1.57

1.23

1.7

3.6

1.02

kg/l

0.59

144

(3013115) Eosinophils [#/volume] in Blood

541

1.48

1.21

6.8

7.2

0.20

0.19

e9/l

0.22

490

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

302

1.50

1.20

4.1

3.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

230

1.55

1.20

1.8

1.6

19.56

21.74

nmol/l

0.40

204

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.79

1.14

3.5

7.9

104.27

104.84

mmol/l

0.19

(40768797) Stomach Pathology biopsy report

113

1.71

1.14

1.0

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

138

1.64

1.13

4.0

2.7

2.85

0.80

e6/l

0.76

(3012544) pH of Venous blood

1.77

1.10

5.4

4.2

7.38

—

(3015736) pH of Urine

411

1.44

1.09

3.1

3.2

6.11

6.23

0.36

221

(3003327) Ova and parasites identified in Stool by Light microscopy

2.09

1.08

1.4

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

800

1.55

1.05

5.0

4.6

14.37

14.52

pmol/l

0.28

750

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.33

1.04

1.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

801

1.54

1.03

3.7

3.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

104

977

1.90

1.02

15.7

13.3

18.75

19.99

mg/l

0.15

770

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.07

1.02

2.9

2.1

—

(3003694) ABO and Rh group [Type] in Blood

341

1.42

0.98

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

127

1.60

0.96

4.3

2.8

3.60

4.41

e6/l

0.15

(3030467) Casts [#/volume] in Urine by Automated count

251

1.45

0.94

4.3

2.8

0.34

0.29

e6/l

0.12

183

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.21

0.93

1.2

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

101

943

1.72

0.91

14.9

13.8

139.34

139.76

mmol/l

1.14

101

927

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.06

0.88

1.0

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

101

946

1.69

0.85

14.6

13.8

4.00

3.92

mmol/l

2.12

101

928

(3007164) IgA [Mass/volume] in Serum or Plasma

283

1.40

0.85

2.0

1.4

2.40

2.09

g/l

0.52

169

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

166

1.49

0.84

2.0

3.2

721.33

532.31

ng/l

0.25

139

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

360

1.37

0.82

2.3

1.9

91.00

95.13

pmol/l

0.24

186

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.86

0.80

2.5

2.2

—

(3000850) Epithelial cells [#/volume] in Urine

195

1.43

0.79

2.9

2.8

8.72

7.62

e6/l

0.08

174

(36660697) Celiac disease serology panel - Serum

125

1.52

0.79

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.23

0.77

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.23

0.77

1.0

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

251

1.38

0.76

4.2

4.7

—

(4034850) Laboratory test

2.13

0.75

3.8

6.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1.90

0.75

2.3

2.2

—

4.64

—

(3032080) INR in Blood by Coagulation assay

319

1.34

0.71

6.7

8.0

1.05

1.08

inr

0.18

265

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

855

1.43

0.69

16.6

16.4

13.34

0.01

848

(3035933) Granulocytes/Leukocytes in Blood

1.89

0.69

2.4

4.2

57.60

61.24

—

(3023368) Bacteria identified in Blood by Culture

209

1.38

0.69

3.3

4.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.67

0.67

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

123

1.45

0.62

1.2

1.4

—

(40761511) CBC panel - Blood by Automated count

105

1006

1.70

0.62

12.4

11.6

—

(3000492) Spirometry study

106

1.48

0.61

1.2

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

151

1.40

0.59

1.9

1.5

496.00

489.33

titre

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1.75

0.59

1.8

1.5

0.19

0.23

g/l

—

(3019060) Gas panel - Arterial blood

1.75

0.59

4.0

17.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

263

1.30

0.56

2.1

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.47

0.54

1.1

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

227

1.31

0.54

1.3

30.97

23.27

iu/ml

—

(3044640) Blood type and Crossmatch panel - Blood

307

0.76

0.53

1.8

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

210

1.31

0.51

2.1

1.8

1.06

0.69

mg/l

0.63

167

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.50

0.50

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

142

0.68

0.50

1.5

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.59

0.50

2.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.52

0.48

1.1

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

161

0.71

0.45

1.8

2.2

—

(3013512) EKG study

252

1.26

0.44

4.4

2.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

584

1.22

0.44

9.7

10.8

3.72

3.94

e9/l

0.57

523

(1761868) Lipid panel - Serum or Plasma

416

1.22

0.44

2.4

2.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

243

1.26

0.43

1.9

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.47

0.43

1.6

1.4

—

(3020891) Body temperature

1.59

0.43

7.2

4.0

37.00

36.98

°c

—

(40768804) Tissue Pathology biopsy report

359

1.22

0.42

1.9

2.0

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

0.41

0.0

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

0.41

0.0

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

0.41

0.0

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

0.41

0.0

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

105

1015

1.55

0.41

16.9

14.8

70.80

68.73

umol/l

0.46

105

1000

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.4

—

(3018095) Leukocytes [#/volume] in Urine

350

1.22

0.41

5.1

3.7

19.05

28.21

e6/l

0.39

231

(42870588) Differential panel, method unspecified - Blood

322

1.22

0.40

6.4

6.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.39

0.0

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.39

0.0

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.39

0.0

2.2

—

6.84

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

365

1.19

0.35

5.8

8.4

1.22

mmol/l

0.00

342

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.39

0.33

2.3

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

147

1.27

0.33

1.7

4.3

0.83

0.81

mmol/l

0.28

136

(3011288) Drugs identified in Urine by Screen method Nominal

1.40

0.32

1.7

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.34

0.31

1.6

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.29

0.30

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

312

1.18

0.29

1.3

5.26

1.54

u/ml

—

(40758558) Short blood count panel - Blood

313

1.17

0.28

4.3

6.7

—

(3022145) Colonoscopy Study observation

1.29

0.27

1.3

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.31

0.25

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

201

1.18

0.23

1.5

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

317

1.15

0.23

2.0

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

221

1.17

0.22

1.5

1.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.23

0.22

1.8

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

104

1018

1.30

0.22

11.0

10.6

26.09

25.90

u/l

0.05

104

999

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1.20

0.22

1.6

8.9

24.06

24.46

mmol/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.21

0.0

1.5

—

92.43

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.21

0.0

1.1

—

(3021788) Differential panel - Synovial fluid

0.00

0.21

0.0

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

153.38

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

0.21

0.0

1.4

—

13.34

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

271

1.15

0.21

1.6

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.20

0.0

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.20

0.0

1.5

—

(3044941) Cell count panel - Synovial fluid

0.00

0.20

0.0

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.20

0.0

1.8

—

9.93

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.21

0.20

1.2

1.6

71.40

52.34

ug/l

—

(3012516) Albumin [Mass/volume] in Urine

214

1.15

0.19

5.2

3.2

23.71

60.27

mg/l

0.99

137

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.20

0.18

2.1

10.1

23.64

24.71

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.18

0.18

1.6

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.16

0.18

5.1

4.8

23.26

23.94

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

449

0.90

0.18

2.6

3.1

—

estimate

—

(3000991) Gas panel - Venous blood

1.19

0.17

5.9

10.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

217

1.13

0.16

6.1

3.7

3.72

10.63

mg/mmol

1.18

134

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

140

1.17

0.16

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.81

0.15

3.4

4.9

—

(40761536) Microorganisms panel - Urine sediment

1.20

0.15

2.4

3.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

118

0.83

0.15

2.0

2.1

—

(3042936) Bacteria identified in Isolate by Culture

133

1.15

0.12

1.9

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.17

0.10

1.2

1.7

1.40

2.58

ug/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.09

0.10

1.0

1.1

1.50

1.58

g/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.09

0.10

1.0

1.1

—

0.59

—

(3002256) Pathology report gross observation

124

0.87

0.09

1.4

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.04

0.09

1.0

1.2

0.80

0.85

g/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

216

0.91

0.09

1.8

2.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

224

1.09

0.09

2.6

3.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.06

0.08

1.0

1.5

—

(4035726) Immunohistochemistry procedure

1.10

0.08

1.0

1.4

—

(3008898) HLA-B27 [Presence]

1.08

0.08

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.84

0.08

1.8

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

108

1.12

0.07

4.8

8.5

1.08

1.10

mmol/l

0.14

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.09

0.07

3.2

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

1.02

0.07

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

149

1.09

0.05

3.4

5.70

256.91

ng/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

189

0.94

0.03

1.4

1.6

—

(3018418) pH of Serum or Plasma

241

1.05

0.03

4.9

4.1

7.41

7.40

0.31

167

(3026008) Bacteria identified in Urine by Culture

264

1.03

0.00

2.9

2.6

—

(3029937) Albumin [Presence] in Urine by Test strip

278

1.01

0.00

3.6

3.9

0.00

estimate

-0.00

107

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

103

0.97

0.00

1.7

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

243

0.98

0.00

1.3

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

343

0.99

0.00

1.9

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

285

1.02

0.00

5.0

2.8

10.10

20.34

ng/l

2.10

149

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

211

0.99

0.00

1.5

1.3

1.18

7.99

u/ml

1.87

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3025941) Bacteria identified in Stool by Culture

0.86

0.00

1.0

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.2

—

46.18

—

(3024263) Appearance of Synovial fluid

0.00

0.0

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

130.17

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

0.0

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3028300) Cannabinoids [Presence] in Urine

1.00

-0.00

1.6

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

110

1.00

-0.00

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.2

—

36.00

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

1.00

-0.00

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

5.82

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

1.1

—

154.57

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.95

-0.00

1.3

1.4

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.60

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.90

-0.00

1.0

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

2.83

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

0.90

-0.00

6.6

4.9

1.23

1.22

mmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

0.96

-0.00

3.7

4.5

—

21.58

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

100

1.00

-0.00

1.8

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

400

1.00

-0.00

1.5

1.9

1.37

1.36

mmol/l

0.03

354

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

11.26

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

10.40

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.93

-0.00

1.5

1.9

—

(3022313) Gas panel - Capillary blood

1.00

-0.00

1.6

11.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

2.94

—

(3012565) Volume of 24 hour Urine

0.00

-0.00

0.0

1.0

—

2259.00

—

(3016879) Cocaine [Presence] in Urine

0.94

-0.00

1.6

—

(3027008) Opiates [Presence] in Urine

1.00

-0.00

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

8.1

—

128.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint FOOD_ALLERGY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have FOOD_ALLERGY.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: FOOD_ALLERGY – Food allergy

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Food allergy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints